NALDINI, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 467
EU - Europa 451
AS - Asia 149
AF - Africa 1
Totale 1068
Nazione #
US - Stati Uniti d'America 448
CN - Cina 130
SE - Svezia 93
IT - Italia 66
FR - Francia 59
UA - Ucraina 52
IE - Irlanda 44
DE - Germania 41
FI - Finlandia 20
CA - Canada 19
GB - Regno Unito 18
BE - Belgio 16
KR - Corea 15
PL - Polonia 15
RU - Federazione Russa 10
GR - Grecia 6
NL - Olanda 3
RO - Romania 3
JP - Giappone 2
AT - Austria 1
EE - Estonia 1
HU - Ungheria 1
IN - India 1
LT - Lituania 1
PT - Portogallo 1
SN - Senegal 1
VN - Vietnam 1
Totale 1068
Città #
Beijing 111
Ann Arbor 95
Dublin 44
Chandler 39
Dearborn 29
Villeurbanne 24
Wilmington 21
Medford 19
Fairfield 18
Jacksonville 17
Houston 15
Princeton 14
Warsaw 14
Milan 13
Brussels 12
Toronto 11
Nyköping 10
Ashburn 8
Seattle 8
Redwood City 7
Boardman 6
Düsseldorf 6
Guangzhou 6
Woodbridge 6
Lachine 5
Torino 5
Verona 5
Athens 4
Boston 4
Cambridge 4
Fremont 4
Pisa 4
Abbiategrasso 3
Falls Church 3
Gent 3
San Mateo 3
Broomfield 2
Buffalo 2
Hanover 2
Jinan 2
Marcq-en-baroeul 2
Monmouth Junction 2
Muenster 2
Norwalk 2
Padova 2
San Diego 2
Silver Spring 2
Tokyo 2
Turin 2
Alba 1
Antea 1
Augusta 1
Bethesda 1
Bloomfield 1
Budapest 1
Canterbury 1
Cattolica 1
Centereach 1
Cincinnati 1
Como 1
Dong Ket 1
Genova 1
Glasgow 1
Haikou 1
Hefei 1
Heidelberg 1
Horia 1
Las Vegas 1
Leawood 1
Los Angeles 1
Magdeburg 1
Montréal 1
Münster 1
Nürnberg 1
Piemonte 1
Porto 1
Provo 1
Salerno 1
San Francisco 1
San Jose 1
Sant'elena 1
Shanghai 1
Sheffield 1
Shenyang 1
Shenzhen 1
Tacoma 1
Tallinn 1
Tyresö 1
Vancouver 1
Vienna 1
Vilnius 1
Vorselaar 1
Winston Salem 1
Wuhan 1
Xian 1
Zhengzhou 1
Totale 673
Nome #
Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models 178
Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. 168
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. 119
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. 116
RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis 92
The MET oncogene drives a genetic programme linking cancer to haemostasis 68
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient 58
Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. 57
Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence 57
Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells. 55
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 51
Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors 48
MiR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages 32
Totale 1099
Categoria #
all - tutte 1800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018118 0000 00 00 883000
2018/201964 0141 06 49 67215
2019/2020164 212912 1031 225 1218184
2020/2021149 1211510 2211 286 912617
2021/2022304 17171736 1313 2821 6317233
2022/2023162 20547 1544 2524 18000
Totale 1099